Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | PKM | P14618 | 1/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.68 |
| ▸ | CA1 | P00915 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.54 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.54 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.54 |
| ▸ | GBA1 | P04062 | 2/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5015149 | 0.98 | CYP3A4 (0.67) | CYP3A4ALDH1A1KDM4ELMNAPKM | |
| SCHEMBL6437093 | 0.88 | ALDH1A1 (0.75) | CYP3A4ALDH1A1KDM4ELMNAPKM | |
| Hydrochloric Acid SCHEMBL29141937 | 0.87 | CYP3A4 (0.64) | CYP3A4ALDH1A1KDM4ELMNAPKM | |
| SCHEMBL8349568 | 0.87 | ALDH1A1 (0.79) | ALDH1A1KDM4ELMNAPKMSMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL1580262 | 0.87 | CYP3A4 (0.54) | CYP3A4ALDH1A1KDM4ELMNAPKM | |
| SCHEMBL6671584 | 0.86 | ALDH1A1 (0.79) | CYP3A4ALDH1A1KDM4ELMNAPKM | |
| SCHEMBL11649813 | 0.85 | ALDH1A1 (0.82) | CYP3A4ALDH1A1KDM4ELMNAPKM | |
| SCHEMBL11807867 | 0.85 | ALDH1A1 (0.82) | CYP3A4ALDH1A1KDM4ELMNAPKM | |
| SCHEMBL11623917 | 0.85 | ALDH1A1 (0.82) | CYP3A4ALDH1A1KDM4ELMNAPKM | |
| Hydrochloric Acid SCHEMBL11628667 | 0.83 | ALDH1A1 (0.79) | CYP3A4ALDH1A1KDM4ELMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114235990-B | Tuberculosis serum marker screening method and application | 宁夏医科大学 | 2024-11-26 | — | — | CN | claimed |
| EP-3483166-B1 | IMIDAZOOXAZOLE DERIVATIVE HAVING ANTITUMOR EFFECT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | KOREA INST SCI & TECH (KR) | 2023-11-01 | — | — | EP | claimed |
| EP-3845539-B1 | IMIDAZOOXAZOLE DERIVATIVE HAVING ANTITUMOR EFFECT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | KOREA INST SCI & TECH (KR) | 2022-11-16 | — | — | EP | claimed |
| CN-114235990-A | Tuberculosis serum marker screening method and application | 宁夏医科大学 | 2022-03-25 | — | — | CN | claimed |
| CN-109689659-B | Imidazooxazole derivative having anti-tumor effect and pharmaceutical composition comprising the same | 韩国科学技术研究院 | 2022-01-28 | — | — | CN | claimed |
| CN-113121564-A | Imidazooxazole derivative having anti-tumor effect and pharmaceutical composition comprising the same | 韩国科学技术研究院 | 2021-07-16 | — | — | CN | claimed |
| EP-3845539-A1 | IMIDAZOOXAZOLE DERIVATIVE HAVING ANTITUMOR EFFECT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | Korea Institute of Science and Technology (KR) | 2021-07-07 | — | — | EP | claimed |
| US-20200131199-A1 | IMIDAZOOXAZOLE DERIVATIVE HAVING ANTITUMOR EFFECT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2020-04-30 | — | — | US | claimed |
| US-10570155-B2 | Imidazooxazole derivative having antitumor effect, and pharmaceutical composition including same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2020-02-25 | — | — | US | claimed |
| CN-110256345-A | A kind of preparation method of gliquidone intermediate | 天津药物研究院药业有限责任公司 | 2019-09-20 | — | — | CN | claimed |
| CN-106699658-B | Method for preparing gliquidone intermediate | 天津药物研究院药业有限责任公司 | 2019-06-25 | — | — | CN | claimed |
| CN-109761944-A | A kind of chrysin amide derivatives and preparation method thereof and medical usage | 武汉翼博济生生物科技有限公司 | 2019-05-17 | — | — | CN | claimed |
| EP-3483166-A1 | IMIDAZOOXAZOLE DERIVATIVE HAVING ANTITUMOR EFFECT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | Korea Institute of Science and Technology (KR) | 2019-05-15 | — | — | EP | claimed |
| CN-109689659-A | Imidazo oxazole derivatives with antitumous effect and the pharmaceutical composition including it | 韩国科学技术研究院 | 2019-04-26 | — | — | CN | claimed |
| CN-106699658-A | Method for preparing gliquidone intermediate | 天津药物研究院药业有限责任公司 | 2017-05-24 | — | — | CN | claimed |
| CN-106397339-A | Preparation method of 2-[4-aminosulfonyl-phenyl]-ethyl-5-methylpyrazine formamide | 天津市亨必达化学合成物有限公司 | 2017-02-15 | — | — | CN | claimed |
| EP-0783366-B1 | CHROMATOGRAPHIC RESINS AND METHODS FOR USING SAME | UNIV MASSEY (NZ) | 2004-08-18 | — | — | EP | claimed |
| US-5652348-A | SOLID SUPPORT MATRIX, IONIZABLE LIGANDS SELECTED RELATIVE TO TARGET COMPOUND | MASSEY UNIVERSITY (NZ) | 1997-07-29 | — | — | US | claimed |
| EP-0783366-A1 | CHROMATOGRAPHIC RESINS AND METHODS FOR USING SAME | MASSEY UNIVERSITY (NZ) | 1997-07-16 | — | — | EP | claimed |
| WO-1996009116-A1 | CHROMATOGRAPHIC RESINS AND METHODS FOR USING SAME | MASSEY UNIVERSITY (NZ) | 1996-03-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200131199-A1 | IMIDAZOOXAZOLE DERIVATIVE HAVING ANTITUMOR EFFECT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | TPMT, MYD88, IDO1 | CYP3A4 92/4885ALDH1A1 1785/4885KDM4E 1471/4885 |
| US-10570155-B2 | Imidazooxazole derivative having antitumor effect, and pharmaceutical composition including same | TPMT, MYD88, IDO1 | CYP3A4 92/4885ALDH1A1 1785/4885KDM4E 1471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.